Carregant...
Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy
Receptor tyrosine kinase (RTK)-related genes, including HER2, EGFR, MET, FGFR2 and KRAS, are target molecules that are clinically beneficial in gastric cancer (GC). We investigated the correlation between RTK-related genes and the curative effect of first-line S-1 plus cisplatin (SP) combination che...
Guardat en:
Publicat a: | Genes Cancer |
---|---|
Autors principals: | , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Impact Journals LLC
2016
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4773703/ https://ncbi.nlm.nih.gov/pubmed/27014419 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|